152 related articles for article (PubMed ID: 8542606)
1. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
Bacon BE; Cherniak R
Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606
[TBL] [Abstract][Full Text] [Related]
2. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
[TBL] [Abstract][Full Text] [Related]
3. Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy.
Sheng S; Cherniak R
Carbohydr Res; 1997 Jun; 301(1-2):33-40. PubMed ID: 9228737
[TBL] [Abstract][Full Text] [Related]
4. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
[TBL] [Abstract][Full Text] [Related]
5. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.
Cherniak R; Morris LC; Belay T; Spitzer ED; Casadevall A
Infect Immun; 1995 May; 63(5):1899-905. PubMed ID: 7729900
[TBL] [Abstract][Full Text] [Related]
6. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
Turner SH; Cherniak R
Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
[TBL] [Abstract][Full Text] [Related]
7. Complete assignment of the 1H- and 13C-n.m.r. spectra of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype B.
Skelton MA; van Halbeek H; Cherniak R
Carbohydr Res; 1991 Dec; 221():259-68. PubMed ID: 1816923
[No Abstract] [Full Text] [Related]
8. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.
Cherniak R; Jones RG; Reiss E
Carbohydr Res; 1988 Jan; 172(1):113-38. PubMed ID: 3280130
[TBL] [Abstract][Full Text] [Related]
9. The structure of a
Hargett AA; Azurmendi HF; Crawford CJ; Wear MP; Oscarson S; Casadevall A; Freedberg DI
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2315733121. PubMed ID: 38330012
[No Abstract] [Full Text] [Related]
10. Synthesis of a hexasaccharide, the repeating unit of O-deacetylated GXM of C. neoformans serotype A.
Zhang J; Kong F
Carbohydr Res; 2003 Aug; 338(17):1719-25. PubMed ID: 12892938
[TBL] [Abstract][Full Text] [Related]
11. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.
McFadden DC; Fries BC; Wang F; Casadevall A
Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878
[TBL] [Abstract][Full Text] [Related]
12. Facile synthesis of the heptasaccharide repeating unit of O-deacetylated GXM of C. neoformans serotype B.
Zhao W; Kong F
Bioorg Med Chem; 2005 Jan; 13(1):121-30. PubMed ID: 15582457
[TBL] [Abstract][Full Text] [Related]
13.
Kuttel MM; Casadevall A; Oscarson S
Molecules; 2020 Jun; 25(11):. PubMed ID: 32517333
[TBL] [Abstract][Full Text] [Related]
14. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Ikeda R; Maeda T
Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
[TBL] [Abstract][Full Text] [Related]
15. Protein-polysaccharide interactions. A monoclonal antibody specific for the capsular polysaccharide of Cryptococcus neoformans.
Otteson EW; Welch WH; Kozel TR
J Biol Chem; 1994 Jan; 269(3):1858-64. PubMed ID: 8294434
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
Todaro-Luck F; Reiss E; Cherniak R; Kaufman L
Infect Immun; 1989 Dec; 57(12):3882-7. PubMed ID: 2680986
[TBL] [Abstract][Full Text] [Related]
17. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
Belay T; Cherniak R
Infect Immun; 1995 May; 63(5):1810-9. PubMed ID: 7537249
[TBL] [Abstract][Full Text] [Related]
18. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.
McFadden DC; Casadevall A
J Immunol; 2004 Mar; 172(6):3670-7. PubMed ID: 15004170
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.
Cherniak R; Valafar H; Morris LC; Valafar F
Clin Diagn Lab Immunol; 1998 Mar; 5(2):146-59. PubMed ID: 9521136
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a heptasaccharide fragment of the O-deacetylated GXM of C. neoformans serotype C.
Zhao W; Kong F
Carbohydr Res; 2005 Jul; 340(10):1673-81. PubMed ID: 15927170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
